Elevance Health (ELV) Long-Term Investments (2009 - 2026)

Elevance Health (ELV) has reported Long-Term Investments for 18 consecutive years, with $11.1 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Long-Term Investments rose 923.92% year-over-year to $11.1 billion; the TTM figure through Jun 2026 stood at $11.1 billion (up 923.92% YoY), while the FY2025 annual figure was $1.1 billion, up 8.31% from the prior year.
• Long-Term Investments improved to $11.1 billion in Q2 2026 per ELV's latest filing, from $1.1 billion in the prior quarter.
• Across five years, Long-Term Investments topped out at $11.1 billion in Q2 2026 and bottomed at $467.0 million in Q2 2022.
• Historically, Long-Term Investments has averaged $2.0 billion across 5 years, with a median of $964.0 million in 2024.
• Annual changes were most pronounced in 2023 — Long-Term Investments soared 1043.55% — and 2024, when it sank 85.4%.
• Elevance Health's Long-Term Investments stood at $581.0 million in 2022, then jumped by 50.77% to $876.0 million in 2023, then rose by 18.15% to $1.0 billion in 2024, then rose by 8.31% to $1.1 billion in 2025, then surged by 892.86% to $11.1 billion in 2026.
• Business Quant data shows ELV's Long-Term Investments at $11.1 billion in Q2 2026, $1.1 billion in Q1 2026, and $1.1 billion in Q4 2025.